Qube Research & Technologies (QRT)’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.21M | Sell |
346,928
-740,415
| -68% | -$4.72M | ﹤0.01% | 1560 |
|
|
2025
Q1 | $5.28M | Buy |
1,087,343
+271,550
| +33% | +$1.32M | 0.01% | 1172 |
|
|
2024
Q4 | $7.8M | Buy |
815,793
+477,845
| +141% | +$4.57M | 0.01% | 966 |
|
|
2024
Q3 | $2.82M | Buy |
337,948
+63,794
| +23% | +$533K | ﹤0.01% | 1294 |
|
|
2024
Q2 | $1.87M | Buy |
+274,154
| New | +$1.87M | ﹤0.01% | 1394 |
|
|
2024
Q1 | – | Sell |
-621,177
| Closed | -$1.49M | – | 4021 |
|
|
2023
Q4 | $1.49M | Buy |
+621,177
| New | +$1.49M | ﹤0.01% | 1441 |
|
|
2023
Q3 | – | Sell |
-36,158
| Closed | -$266K | – | 3700 |
|
|
2023
Q2 | $266K | Buy |
+36,158
| New | +$266K | ﹤0.01% | 1618 |
|
|
2023
Q1 | – | Sell |
-135,889
| Closed | -$1.6M | – | 2588 |
|
|
2022
Q4 | $1.6M | Buy |
135,889
+91,261
| +204% | +$1.08M | 0.01% | 963 |
|
|
2022
Q3 | $937K | Buy |
44,628
+22,089
| +98% | +$464K | 0.01% | 1184 |
|
|
2022
Q2 | $700K | Buy |
22,539
+474
| +2% | +$14.7K | 0.01% | 1258 |
|
|
2022
Q1 | $906K | Buy |
+22,065
| New | +$906K | 0.01% | 1204 |
|
|
2021
Q4 | – | Sell |
-14,355
| Closed | -$719K | – | 2624 |
|
|
2021
Q3 | $719K | Buy |
14,355
+4,689
| +49% | +$235K | 0.01% | 1037 |
|
|
2021
Q2 | $609K | Buy |
+9,666
| New | +$609K | 0.01% | 1171 |
|
|
2020
Q4 | – | Sell |
-18,530
| Closed | -$1.92M | – | 1894 |
|
|
2020
Q3 | $1.92M | Buy |
+18,530
| New | +$1.92M | 0.03% | 644 |
|